|
Robert Conrad has always had a sincere passion for medical research in combination with product development. Considering that his background includes a family of doctors and nurses with a history rich in medical discovery, it is no wonder that the creation of Tyrell, Inc. and the groundbreaking Zeno? evolved from his efforts.
After he read an article on heat shock response, and after the unfortunate appearance of a large pimple before an important board meeting, Conrad began work in 1997 on the early stages of what became the first Zeno prototype. In late 2002, during lab testing conducted with the assistance of Dr. Charles Conrad, M.D. (Robert’s brother, a highly acclaimed neuro-oncologist at M.D. Anderson Cancer Center in Houston, Texas and chief medical officer of Tyrell), in only two weeks of initial lab research, it was confirmed that the technology behind Zeno wiped out 90 percent of acne-causing bacteria in a single two-and-a-half-minute treatment. The result was the birth of Zeno, a revolutionary new home-based medical device for over-the-counter treatment of acne.
As the founder and chief operating officer for Tyrell, Inc., Conrad oversees all clinical research and product development, including FDA approval.
Before he founded Tyrell, Conrad’s entrepreneurial positions included president, CEO, and owner of a company that provided biologic testing services. He also previously served as founder, owner, and vice president of operations of Iatro Research, Inc., a biotech company primarily focused on microbiology and genetic engineering. His professional experience includes previous executive-level management positions in the financial industries. He has also filed 15 U.S. patents.
Conrad earned a B.S. in economics from Texas A&M University. Out of the office, Conrad enjoys spending time with his wife and two children and competing in triathlons.
Zeno
Press Kit
Be sure to visit us in
the near future for updates,
news, and the latest on
Zeno.
For all media inquiries,
please contact Allison
M. Allison at Richards/Gravelle,
214-891-5212 or allison_allison@richards.com.
|